• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,134.32 1,186.77
( 1.65%)
Global Indices
Nasdaq
46,363.90 1,126.75
(2.49%)
Dow Jones
6,550.24 185.52
(2.91%)
Hang Seng
53,589.67 2,525.95
(4.95%)
Nikkei 225
10,364.79 188.34
(1.85%)
Forex
USD-INR
94.31 -0.22
(-0.23%)
EUR-INR
108.30 -0.48
(-0.44%)
GBP-INR
124.69 -0.63
(-0.50%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
848.3143291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
40.58
60201.9
EPS(TTM)
Face Value()
Div & Yield %
52.57
1
0.12
 

As on: Apr 01, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,100.30 -33.00 58874 40.58
Stock Price Details
Open Price() 2,168.30
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,237.30
Today's Low () 2,084.65
52-Week High () 2297.2
152-Week Low () 1336.95
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.12
Eps 52.57
Book Value 848.3143291
Market Cap (.Cr) 60,201.90
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE935A01035


News
Glenmark receives USFDA approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg
Glenmark Pharma secures USFDA nod for Fluticasone Propionate Inhalation Aerosol
Glenmark Pharmaceuticals Inc. to launch Sodium Phosphates Injection USP
Glenmark Pharma’s USA arm to market Sodium Phosphate injection in April 2026
Glenmark Pharmaceuticals Ltd gains for third straight session
Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter
Glenmark Pharmaceuticals to convene board meeting
Benchmarks trade sideways; metal shares shine
Glenmark USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
Glenmark Pharma’s US arm launches Epinephrine Injection in American market
More
Corporate Details
Incoporation Year   : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • BSE Shariah 50
  • MIDCAP 200
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi